| 61/68 | US=20 / Biol/Mol Smiley S, Wong MKK, Mousa SA. Methods for monitoring of the anti-angiogenic activity of agents in patients: novel trial design. In: Staton CA, Lewis C, Bicknell R. Angiogenesis assays: a critical appraisal of current techniques. New Jersey: John Wiley & Sons, 2006. p. 341-59. ISBN 978-0-470-01600-8. METODOS DE MONITORAMENTO DA ATIVIDADE ANTI-ANGIOGENICA; ANGIOGENESE; ENSAIOS CLINICOS; CANCER; DISTURBIOS VASCULARES; IMAGEM; BIOMARCADORES; TERAPIA ADJUNTA |
| 62/68 | US=2-A / Biol/Mol Marks PA. Molecular targets and therapeutics: histone deacetylase inhibitors: development as anticancer agents. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1014-32. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBIDORES DE HISTONA DEACETILASE; AGENTES ANTICANCER; ESTRUTURA DA CROMATINA; HDAC; ENSAIOS CLINICOS |
| 63/68 | US=30 / Pelvis Kelly H, Goldberg RM. Clinical trials and emerging therapies. In: Levin B, Ades T, Brooks D, Crane CH, Hoff PM, Limburg PJ, Rothenberger DA. Complete guide to colorectal cancer. Atlanta: American Cancer Society, 2006. p. 209-20. ISBN 9787-0944235-55-7. CANCER COLORRETAL; ENSAIOS CLINICOS; TERAPIAS EMERGENTES; IMUNOTERAPIA; TERAPIA BASEADA EM GENES |
| 64/68 | US=37 / Câncer Moss RW. The conventional treatment of cancer: the case of non-small cell lung cancer. In: Beuth J, Moss RW. Complementary oncology: adjunctive methods in the treatment of cancer. New York: Thieme, 2006. p. 8-30. ISBN 978-1-5889-0323-0. CANCER; ONCOLOGIA; MEDICINA COMPLEMENTAR; TRATAMENTO CONVENCIONAL DO CANCER; CANCER DE PULMAO NAO-PEQUENAS CELULAS; ENSAIOS CLINICOS; CIRURGIA; RADIOTERAPIA; QUIMIOTERAPIA |
| 65/68 | US=14 / Urologia Hernandez J, Thompson IM Jr. Prostate cancer: prevention of prostate cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 79-85. ISBN 978-0-7817-4984-0. CANCER DE PROSTATA. PREVENCAO; MANIPULACAO HORMONAL; INIBIDORES DE CICLOOXIGENASE-2; DROGAS ANTIINFLAMATORIAS NAO-ESTEROIDES; ANTIOXIDANTES; ENSAIOS CLINICOS; INTERVENCAO DIETETICA |
| 66/68 | US=8 / Quimioterapia Scheinberg DA, Mulford DA, Jurcic JG, Sgouros G, Junghans RP. Antibody therapies of cancer. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 666-98. ISBN 978-0-7817-5628-6. CANCER. TERAPIA; ANTICORPOS; IMUNOGLOBULINA; ONTOGENIA; INTERACAO ANTIGENO-ANTICORPO; FARMACOCINETICA; FARMACODINAMICA; FAGOCITOSE; BLOQUEIO DE RECEPTORES; APOPTOSE; VACINA AB2; RADIOIMUNOTERAPIA; ANTICORPOS MONOCLONAIS; ENSAIOS CLINICOS; RITUXIMABE; ALEMTUZUMABE; HERCEPTINA; BEVACIZUMABE; CETUXIMABE; GEMTUZUMABE OZOGAMICINA |
| 67/68 | US=25 / Biol/Mol Lennan E. From research to treatment: what is translational oncology research?. In: Gabriel J. The biology of cancer. 2nd ed. New Jersey: John Wiley & Sons, 2005. p. 127-34. ISBN 978-0-470-05759-9. PESQUISADORES EM ONCOLOGIA; ENSAIOS CLINICOS; CONCEBER NOVOS TRATAMENTOS; EXECUTAR NOVOS TRATAMENTOS; DIAGNOSTICO; PROGNOSTICO; PREVENCAO |
| 68/68 | US=25 / Biol/Mol Carpenter D. From research to treatment: research ethics relating to cancer. In: Gabriel J. The biology of cancer. 2nd ed. New Jersey: John Wiley & Sons, 2005. p. 153-65. ISBN 978-0-470-05759-9. ETICA EM PESQUISA RELACIONADAS AO CANCER; PESQUISA ANTIETICA; PESQUISADORES; ENSAIOS CLINICOS; COMITES DE ETICA EM PESQUISA; CODIGOS DE ETICA; PARTICIPANTES |